Mpox - Rapidly implementing Disease

Although monkeypox was first discovered in Africa, the majority of cases in the current outbreak are being reported from numerous nations. The origin of this outbreak is still unknown, and as the COVID-19 pandemic starts to fade, several countries are now dealing with a new outbreak. A virus that may infect both humans and animals, monkeypox belongs to the Orthopoxvirus genus within the Poxviridae family. The international community took notice when, in the 1970s, the smallpox immunization program was discontinued and cases of monkeypox started to rise. Since macaque monkeys were the first to contract the virus, it was given the moniker “monkeypox.” It is believed that a variety of rodents and small mammals can spread it, while the virus’s origin is unknown. In this article, we present a thorough and current review of monkeypox, covering its epidemiology, aetiology, pathophysiology, clinical manifestations, diagnosis, and treatment. The present overview also covers prospective research fields, vaccine advancements, and preventive and control methods for this reemerging viral disease that was designated as a public health emergency of international significance. BACKGROUND Mpox is endemic in Central and Western Africa, where it is thought that the virus naturally exists in a number of mammal species. IN 1970, the Democratic Republic of the Congo’s Basankusu saw the diagnosis of the first human cases.Since then, there have been noticeably more outbreaks, both in terms of frequency and intensity, perhaps due to diminishing immunity following the end of routine smallpox vaccination. In 2022–2023, a clade II outbreak occurred worldwide, which was the first instance of broad community transmission beyond Africa. The epidemic was classified as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization in July 2022. As the outbreak began to be contained, the WHO changed its designation in May 2023, noting that vaccination and public health awareness campaigns had been effective control efforts.[1]

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-18
DOI
https://doi.org/10.5281/zenodo.13787539
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mpox - Rapidly implementing Disease

Zenodo (CERN European Organization for Nuclear Research)
Poxvirus research and outbreaks
article

Mpox - Rapidly implementing Disease

article en

Abstract

Although monkeypox was first discovered in Africa, the majority of cases in the current outbreak are being reported from numerous nations. The origin of this outbreak is still unknown, and as the COVID-19 pandemic starts to fade, several countries are now dealing with a new outbreak. A virus that may infect both humans and animals, monkeypox belongs to the Orthopoxvirus genus within the Poxviridae family. The international community took notice when, in the 1970s, the smallpox immunization program was discontinued and cases of monkeypox started to rise. Since macaque monkeys were the first to contract the virus, it was given the moniker “monkeypox.” It is believed that a variety of rodents and small mammals can spread it, while the virus’s origin is unknown. In this article, we present a thorough and current review of monkeypox, covering its epidemiology, aetiology, pathophysiology, clinical manifestations, diagnosis, and treatment. The present overview also covers prospective research fields, vaccine advancements, and preventive and control methods for this reemerging viral disease that was designated as a public health emergency of international significance. BACKGROUND Mpox is endemic in Central and Western Africa, where it is thought that the virus naturally exists in a number of mammal species. IN 1970, the Democratic Republic of the Congo’s Basankusu saw the diagnosis of the first human cases.Since then, there have been noticeably more outbreaks, both in terms of frequency and intensity, perhaps due to diminishing immunity following the end of routine smallpox vaccination. In 2022–2023, a clade II outbreak occurred worldwide, which was the first instance of broad community transmission beyond Africa. The epidemic was classified as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization in July 2022. As the outbreak began to be contained, the WHO changed its designation in May 2023, noting that vaccination and public health awareness campaigns had been effective control efforts.[1]

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 70%
Poxvirus research and outbreaks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.